Banfi C - Search Results

1

Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism.

Eligini S, Violi F, Banfi C, Barbieri SS, Brambilla M, Saliola M, Tremoli E, Colli S. Eligini S, et al. Among authors: banfi c. Cardiovasc Res. 2006 Jan;69(1):218-26. doi: 10.1016/j.cardiores.2005.07.013. Epub 2005 Sep 12. Cardiovasc Res. 2006. PMID: 16154551

2

Plasminogen activator inhibitor type-1 synthesis and mRNA expression in HepG2 cells are regulated by VLDL.

Sironi L, Mussoni L, Prati L, Baldassarre D, Camera M, Banfi C, Tremoli E. Sironi L, et al. Among authors: banfi c. Arterioscler Thromb Vasc Biol. 1996 Jan;16(1):89-96. doi: 10.1161/01.atv.16.1.89. Arterioscler Thromb Vasc Biol. 1996. PMID: 8548432 Free article.

3

Linoleic acid enhances the secretion of plasminogen activator inhibitor type 1 by HepG2 cells.

Banfi C, Risé P, Mussoni L, Galli C, Tremoli E. Banfi C, et al. J Lipid Res. 1997 May;38(5):860-9. J Lipid Res. 1997. PMID: 9186904 Free article.

4

Very low density lipoprotein-mediated signal transduction and plasminogen activator inhibitor type 1 in cultured HepG2 cells.

Banfi C, Mussoni L, Risé P, Cattaneo MG, Vicentini L, Battaini F, Galli C, Tremoli E. Banfi C, et al. Circ Res. 1999 Jul 23;85(2):208-17. doi: 10.1161/01.res.85.2.208. Circ Res. 1999. PMID: 10417403

5

Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells.

Mussoni L, Banfi C, Sironi L, Arpaia M, Tremoli E. Mussoni L, et al. Among authors: banfi c. Thromb Haemost. 2000 Jul;84(1):59-64. Thromb Haemost. 2000. PMID: 10928471 Free article.

6

Transcriptional regulation of plasminogen activator inhibitor type 1 gene by insulin: insights into the signaling pathway.

Banfi C, Eriksson P, Giandomenico G, Mussoni L, Sironi L, Hamsten A, Tremoli E. Banfi C, et al. Diabetes. 2001 Jul;50(7):1522-30. doi: 10.2337/diabetes.50.7.1522. Diabetes. 2001. PMID: 11423472

7

Inhibition of cholesterol biosynthesis as a new antithrombotic strategy.

Tremoli E, Colli S, Camera M, Banfi C, Mussoni L. Tremoli E, et al. Among authors: banfi c. Haematologica. 2001 Nov;86(11 Suppl 2):35. Haematologica. 2001. PMID: 11926773 Review. No abstract available.

8

[PAI-1, the primary plasmatic inhibitor of fibrinolysis. Physiopathologic role and molecular mechanisms].

Banfi C, Mussoni L, Tremoli E. Banfi C, et al. Minerva Endocrinol. 2002 Sep;27(3):181-91. Minerva Endocrinol. 2002. PMID: 12091793 Review. Italian.

9

Oxidized phospholipids inhibit cyclooxygenase-2 in human macrophages via nuclear factor-kappaB/IkappaB- and ERK2-dependent mechanisms.

Eligini S, Brambilla M, Banfi C, Camera M, Sironi L, Barbieri SS, Auwerx J, Tremoli E, Colli S. Eligini S, et al. Among authors: banfi c. Cardiovasc Res. 2002 Aug 1;55(2):406-15. doi: 10.1016/s0008-6363(02)00437-6. Cardiovasc Res. 2002. PMID: 12123780 Free article.

10

Oxidized LDLs influence thrombotic response and cyclooxygenase 2.

Banfi C, Colli S, Eligini S, Mussoni L, Tremoli E. Banfi C, et al. Prostaglandins Leukot Essent Fatty Acids. 2002 Aug-Sep;67(2-3):169-73. doi: 10.1054/plef.2002.0415. Prostaglandins Leukot Essent Fatty Acids. 2002. PMID: 12324237 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

268 results

Search Page

Filters